Polyglutamine (polyQ) diseases, including Huntington’s disease, are characterized by the progressive neuronal degeneration that results from the misfolding and aggregation of proteins that contain expanded repeats of uninterrupted glutamines. There is no cure for polyQ diseases, but increasing the concentration of protein chaperones might prevent some of the protein misfolding, and stop or slow the disease process. Neef et al. performed a pharmacological screen in yeast to identify molecules that increase the production of heat shock transcription factor 1 (HSF1), which regulates levels of protein chaperones in the cell. They identified HSF1A as a chemical activator of human HSF1 in yeast, which leads to Hsp70 expression in rat neurons. HSF1A treatment also reduced the aggregation of polyQ proteins in a Drosophila model of polyQ toxicity. This suggests that HSF1A may alleviate some of the misfolding and aggregation of polyQ proteins that causes neurodegeneration.
Neurodegeneration: proper folding of polyQ proteins
Neurodegeneration: proper folding of polyQ proteins. Dis Model Mech 8 March 2010; 3 (3-4): 122. doi:
Download citation file:
Advertisement
Cited by
DMM Journal Meeting 2024: Pre-clinical Modelling of Human Genetic Disease and Therapy

Registration is now open for our 2024 Journal Meeting. Rapid advances in gene editing and genetic technologies have revolutionised our ability to model human genetic disease and provided new hope for gene therapies. At this Meeting, we will present the very latest advances in modelling human genetic disease.
A new call for papers is underway

Showcase your latest research in our upcoming special issue Translating Multiscale Research in Rare Disease, coordinated by DMM Editors Monica Justice, Karen Liu and Monkol Lek, and Guest Editor Kate Rauen. The deadline for submitting articles to the special issue is Monday 6 November 2023.
Moving towards heart success – Disease Models & Mechanisms Special Issue

DMM's most recent special issue compiles articles that aim to move heart failure to heart success by fundamentally addressing the roots of failure to identify curative strategies.
Adult zebrafish as advanced models of human disease

Editor-in-Chief Liz Patton and Editorial Board member Rich White discuss the unique advantages of adult zebrafish for studying human disease biology. Read the Open Access Editorial here.
The Forest of Biologists

The Forest of Biologists is a biodiversity initiative created by The Company of Biologists, with support from the Woodland Trust. For every Research and Review article published in Disease Models & Mechanisms a native tree is planted in a UK forest. In addition to this we are protecting and restoring ancient woodland and are dedicating these trees to our peer reviewers. Visit our virtual forest to learn more.
Other journals from
The Company of Biologists